Extensive transmission of microbes along the gastrointestinal tract
Abstract
The gastrointestinal tract is abundantly colonized by microbes, yet the translocation of oral species to the intestine is considered a rare aberrant event, and a hallmark of disease. By studying salivary and fecal microbial strain populations of 310 species in 470 individuals from five countries, we found that transmission to, and subsequent colonization of, the large intestine by oral microbes is common and extensive among healthy individuals. We found evidence for a vast majority of oral species to be transferable, with increased levels of transmission in colorectal cancer and rheumatoid arthritis patients and, more generally, for species described as opportunistic pathogens. This establishes the oral cavity as an endogenous reservoir for gut microbial strains, and oral-fecal transmission as an important process that shapes the gastrointestinal microbiome in health and disease.
Data availability
Raw sequencing data have been deposited in the European Nucleotide Archive under project accessions PRJNA289586 and PRJEB28422.
-
The Salivary Microbiome in Health and DiseaseEuropean Nucleotide Archive, PRJEB28422.
-
Human Gut Microbiome in a Multiplex Family Study of Type 1 Diabetes MellitusEuropean Nucleotide Archive, PRJNA289586.
-
The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment.European Nucleotide Archive, PRJEB6997.
-
FijiCOMP: saliva and stool metagenomesEuropean Nucleotide Archive, PRJNA217052.
-
Temporal and technical variability of human gut metagenomes.European Nucleotide Archive, PRJEB8347.
-
Potential of fecal microbiota for early-stage detection of colorectal cancer.European Nucleotide Archive, PRJEB6070.
-
Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes.European Nucleotide Archive, PRJNA289586.
Article and author information
Author details
Funding
Fonds National de la Recherche Luxembourg (CORE/15/BM/10404093)
- Thomas Sebastian Benedikt Schmidt
- Matthew Robert Hayward
- Anna Heintz-Buschart
H2020 European Research Council (ERC-AdG-669830)
- Thomas Sebastian Benedikt Schmidt
- Simone S Li
- Oleksandr M Maistrenko
- Renato JC Alves
- Peer Bork
H2020 Marie Skłodowska-Curie Actions (661019)
- Matthew Robert Hayward
German Network Bioinformatics (de.NBI #031A537B)
- Georg Zeller
- Peer Bork
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: Informed consent was obtained from all study subjects for which novel data was generated; see respective previous publications for details (PMID: 27723761; PMID: 25432777; PMID: 25888008).
Copyright
© 2019, Schmidt et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 15,073
- views
-
- 2,249
- downloads
-
- 392
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Microbiology and Infectious Disease
eLife is pleased to present a Special Issue to highlight recent advances in the mechanistic understanding of microbiome function.
-
- Computational and Systems Biology
- Microbiology and Infectious Disease
Antimicrobial peptides (AMPs) are attractive candidates to combat antibiotic resistance for their capability to target biomembranes and restrict a wide range of pathogens. It is a daunting challenge to discover novel AMPs due to their sparse distributions in a vast peptide universe, especially for peptides that demonstrate potencies for both bacterial membranes and viral envelopes. Here, we establish a de novo AMP design framework by bridging a deep generative module and a graph-encoding activity regressor. The generative module learns hidden ‘grammars’ of AMP features and produces candidates sequentially pass antimicrobial predictor and antiviral classifiers. We discovered 16 bifunctional AMPs and experimentally validated their abilities to inhibit a spectrum of pathogens in vitro and in animal models. Notably, P076 is a highly potent bactericide with the minimal inhibitory concentration of 0.21 μM against multidrug-resistant Acinetobacter baumannii, while P002 broadly inhibits five enveloped viruses. Our study provides feasible means to uncover the sequences that simultaneously encode antimicrobial and antiviral activities, thus bolstering the function spectra of AMPs to combat a wide range of drug-resistant infections.